Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HK1 | P19367 | 4/20 | 0.58 |
| ▸ | HK2 | P52789 | 4/20 | 0.58 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.48 |
| ▸ | HRAS | P01112 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10521162 | 1.00 | HK1 (0.58) | HK1HK2LGALS8HRASALDH1A1 | |
| SCHEMBL12812847 | 1.00 | HK1 (0.58) | HK1HK2LGALS8HRASALDH1A1 | |
| SCHEMBL374488 | 1.00 | HK1 (0.58) | HK1HK2LGALS8HRASALDH1A1 | |
| SCHEMBL9746872 | 1.00 | HK1 (0.58) | HK1HK2LGALS8HRASALDH1A1 | |
| SCHEMBL18803484 | 1.00 | HK1 (0.58) | HK1HK2LGALS8HRASALDH1A1 | |
| SCHEMBL10522400 | 1.00 | HK1 (0.58) | HK1HK2LGALS8HRASALDH1A1 | |
| SCHEMBL7147563 | 1.00 | HK1 (0.58) | HK1HK2LGALS8HRASALDH1A1 | |
| SCHEMBL15763312 | 1.00 | HK1 (0.58) | HK1HK2LGALS8HRASALDH1A1 | |
| SCHEMBL11073387 | 0.89 | ALDH1A1 (0.53) | HK1HK2LGALS8HRASALDH1A1 | |
| SCHEMBL22604145 | 0.88 | LGALS8 (0.49) | HK1HK2LGALS8HRASALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115057898-A | Preparation method of fondaparinux sodium intermediate | 苏州柯默拓医药科技有限公司 | 2022-09-16 | — | — | CN | disclosed |
| US-8399419-B2 | Antibacterial aminoglycoside analogs | ACHAOGEN, INC. (US) | 2013-03-19 | — | — | US | disclosed |